ACCESS announces name change and symbol change on the OTC Bulletin Board.DALLAS--(BUSINESS WIRE)--Jan. 31, 1996--ACCESS Pharmaceuticals, Inc., (formerly Chemex Pharmaceuticals, Inc.), today announced that effective Feb. 1, 1996 its symbol, on the OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. will change from CHMX to AXCS AXCS Senior Chief Aviation Antisubmarine Warfare Technician (Naval Rating) . This change is a result of the merger of the two companies which was completed on Jan. 25, 1996. The name and symbol change does not require an exchange of currently outstanding Chemex Share Certificates. ACCESS Pharmaceuticals is an emerging pharmaceutical company with a broad platform technology for enhancing the site targeting of intravenous therapeutic drugs, MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. contrast agents and radiopharmaceutical radiopharmaceutical /ra·dio·phar·ma·ceu·ti·cal/ (-fahr?mah-soo´ti-k'l) a radioactive pharmaceutical, nuclide, or other chemical used for diagnostic or therapeutic purposes. diagnostic and therapeutic agents. The ACCESS technology is based on natural carbohydrate carriers. The technology development of ACCESS is currently focused on increasing the therapeutic benefit of oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. agents and improving the efficiency of oncology diagnosis by selectively targeting sites of disease and accelerating drug clearance. CONTACT: Access Pharmaceuticals, Inc. Kerry P. Gray, 214/905-5100 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion